[go: up one dir, main page]

DK1246825T3 - Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf - Google Patents

Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf

Info

Publication number
DK1246825T3
DK1246825T3 DK01902310T DK01902310T DK1246825T3 DK 1246825 T3 DK1246825 T3 DK 1246825T3 DK 01902310 T DK01902310 T DK 01902310T DK 01902310 T DK01902310 T DK 01902310T DK 1246825 T3 DK1246825 T3 DK 1246825T3
Authority
DK
Denmark
Prior art keywords
compounds
pyrrole compounds
pharmaceuticals containing
condensed pyrrole
relates
Prior art date
Application number
DK01902310T
Other languages
English (en)
Inventor
Hans-Guenter Striegel
Stefan Laufer
Karola Tollmann
Susanne Tries
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK1246825T3 publication Critical patent/DK1246825T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
DK01902310T 2000-01-13 2001-01-12 Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf DK1246825T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10001166A DE10001166A1 (de) 2000-01-13 2000-01-13 Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
PCT/EP2001/000332 WO2001051491A1 (de) 2000-01-13 2001-01-12 Anellierte pyrrolverbindungen, diese enthaltende pharmazeutische mittel und deren verwendung

Publications (1)

Publication Number Publication Date
DK1246825T3 true DK1246825T3 (da) 2004-04-13

Family

ID=7627401

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902310T DK1246825T3 (da) 2000-01-13 2001-01-12 Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf

Country Status (16)

Country Link
US (1) US6936632B2 (da)
EP (1) EP1246825B1 (da)
JP (1) JP2003525875A (da)
KR (1) KR20020081254A (da)
CN (1) CN1191254C (da)
AT (1) ATE256685T1 (da)
AU (1) AU2001230180A1 (da)
CA (1) CA2396413A1 (da)
DE (2) DE10001166A1 (da)
DK (1) DK1246825T3 (da)
ES (1) ES2213102T3 (da)
MX (1) MXPA02006863A (da)
NO (1) NO323238B1 (da)
PT (1) PT1246825E (da)
TR (1) TR200400270T4 (da)
WO (1) WO2001051491A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
NZ531226A (en) 2001-08-30 2006-07-28 Merckle Gmbh Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
CN117756811A (zh) * 2023-12-29 2024-03-26 贵州民族大学 一种合成多取代基吡咯化合物的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
ATE17480T1 (de) 1982-03-03 1986-02-15 Du Pont Entzuendungshemmende und/oder schmerzstillende 2,3-diaryl-5-halo thiophene.
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
EP0679157B1 (en) 1993-01-15 1997-11-19 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5344991A (en) 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
US5475018A (en) 1993-11-30 1995-12-12 G. D. Searle & Co. 1,5-diphenyl pyrazole compounds for treatment of inflammation
AU692231B2 (en) 1994-02-10 1998-06-04 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation
US5418254A (en) 1994-05-04 1995-05-23 G. D. Searle & Co. Substituted cyclopentadienyl compounds for the treatment of inflammation
DE4419246A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
AU6111796A (en) * 1995-06-12 1997-01-09 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor
DE19624290A1 (de) 1996-06-18 1998-01-02 Merckle Gmbh Verwendungen von Pyrrolizin-Verbindungen in der Pharmazie
DE19624289A1 (de) 1996-06-18 1998-01-02 Merckle Gmbh Pyrrolizin-Verbindungen und deren Verwendung
WO1999061016A1 (fr) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Inhibiteurs de cyclo-oxygenase-2
DE19845446A1 (de) 1998-10-02 2000-04-06 Merckle Gmbh Antiinflammatorische Oxo- und Hydroxyderivate von Pyrrolizinen und deren Verwendung in der Pharmazie
ES2291577T3 (es) 1999-11-23 2008-03-01 Merckle Gmbh Derivados oxo e hidroxi de pirrolizinas antiinflamatorios y su aplicacion en farmacia.
DE10004157A1 (de) 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie

Also Published As

Publication number Publication date
MXPA02006863A (es) 2004-04-05
EP1246825A1 (de) 2002-10-09
JP2003525875A (ja) 2003-09-02
CA2396413A1 (en) 2001-07-19
TR200400270T4 (tr) 2004-03-22
ES2213102T3 (es) 2004-08-16
DE10001166A1 (de) 2001-07-19
EP1246825B1 (de) 2003-12-17
ATE256685T1 (de) 2004-01-15
CN1418217A (zh) 2003-05-14
KR20020081254A (ko) 2002-10-26
PT1246825E (pt) 2004-04-30
NO323238B1 (no) 2007-02-05
US20040122002A1 (en) 2004-06-24
AU2001230180A1 (en) 2001-07-24
CN1191254C (zh) 2005-03-02
NO20023363L (no) 2002-09-10
WO2001051491A1 (de) 2001-07-19
DE50101187D1 (de) 2004-01-29
NO20023363D0 (no) 2002-07-12
US6936632B2 (en) 2005-08-30

Similar Documents

Publication Publication Date Title
DK1263730T3 (da) Aminderivater til behandling af apoptose
DE60142921D1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
ATE369370T1 (de) Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren
DK1268471T3 (da) N-heterocykliske derivater som NOS-inhibitorer
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ATE301653T1 (de) Pyrazolopyridine
EA199900448A1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
MXPA02011425A (es) Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa.
SE0300119D0 (sv) Novel compounds
NO20035583D0 (no) Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
DK1246809T3 (da) 5-aryl-1H-1,2,4-triazolforbindelser som inhibitor for cyclooxygenase-2 og farmaceutiske sammensætninger som indeholder dem
ATE300541T1 (de) Pyrazolopyridinderivate
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
SE9804212D0 (sv) Compounds
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
DK1246825T3 (da) Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
ATE274515T1 (de) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds